Skip to the page

Data / Medical devices / United States / Luminex Corporation

Luminex Corporation: FDA-registered device maker in Austin, TX, United States, 7 510(k) clearances

Luminex Corporation is registered with the FDA (registration 1650733) in Austin, TX, United States. It lists 10 device types. The FDA files 7 510(k) clearances under its listings, the newest dated April 12, 2016. 14 recall events name it as the recalling firm. Registered through 2026. FDA data exported November 3, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
1650733
FEI number
3002524000
Address
12212 Technology Blvd, Austin, TX, United States, 78727
Owner or operator
Luminex Corporation (9032042)
Roles
Complaint file establishment, Contract manufacturer, Manufacturer, Remanufacturer
First device listed
April 16, 2008
Registered through
2026
Brand names listed
FLEXMAP 3D, Gastrointestinal Pathogen Panel (GPP), LIAISON PLEX System, Luminex 100, Luminex 100/200, Luminex 200, MAGPIX, MAGPIX® Drive Fluid PLUS (4PK) and more

Devices it lists

DeviceProduct codeClassRoleSource
Bordetella Pertussis Dna Assay SystemOZZ2Complaint file establishment, Manufacturer, Remanufactureraccessdata.fda.gov
Clinical Sample ConcentratorJJH1Manufactureraccessdata.fda.gov
Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay SystemPCH2Manufactureraccessdata.fda.gov
Human Metapneumovirus (Hmpv) Rna Assay SystemOEM2Complaint file establishment, Manufacturer, Remanufactureraccessdata.fda.gov
Influenza A And Influenza B Multiplex Nucleic Acid AssayOZE2Complaint file establishment, Manufacturer, Remanufactureraccessdata.fda.gov
Influenza A Virus Subtype Differentiation Nucleic Acid AssayOEP2Complaint file establishment, Manufacturer, Remanufactureraccessdata.fda.gov
Instrumentation For Clinical Multiplex Test SystemsNSU2Contract manufacturer, Manufactureraccessdata.fda.gov
Parainfluenza Multiplex Nucleic Acid AssayOOU2Complaint file establishment, Manufacturer, Remanufactureraccessdata.fda.gov
Real Time Nucleic Acid Amplification SystemOOI2Complaint file establishment, Manufacturer, Remanufactureraccessdata.fda.gov
Respiratory Virus Panel Nucleic Acid Assay SystemOCC2Complaint file establishment, Manufacturer, Remanufactureraccessdata.fda.gov

510(k) clearances

The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.

Decided510(k) numberDeviceProduct codeDecisionApplicantSource
April 12, 2016K160517ARIES SystemOOISubstantially EquivalentLuminex Corporationaccessdata.fda.gov
December 17, 2015K152386NxTAG Respiratory Pathogen Panel, NxTAG Respiratory Pathogen Panel Files, SYNCT SoftwareOCCSubstantially EquivalentLuminex Molecular Diagnostics, Inc.accessdata.fda.gov
September 4, 2015K143653Verigene Respiratory Pathogens Flex Nucleic Acid Test (RP Flex)OCCSubstantially EquivalentNanosphere, Inc.accessdata.fda.gov
January 10, 2014K133302FLEXMAP 3DNSUSubstantially EquivalentLuminex Corp.accessdata.fda.gov
March 21, 2013K121894XTAG GASTROINTESTINAL PATHOGEN PANEL(GPP) XTAG DATA ANALYSIS SOFTWARE FOR GPP (TDAS GPP) LUMINEX MAGPIXPCHSubstantially EquivalentLuminex Molecular Diagnostics, Inc.accessdata.fda.gov
January 9, 2013K121399LUMINEX FLEXMAP 3D INSTRUMENT SYSTEM, LUMINEX XPONENT 4.0 SPI SOFTWARE, FLEXMAP 3D IVD CALIBRATION KIT, FLEXMAP 3D IVD PNSUSubstantially EquivalentLuminex Corp.accessdata.fda.gov
March 7, 2008K073506LUMINEX LX 100/200 INSTRUMENTNSUSubstantially EquivalentLuminex Corp.accessdata.fda.gov

Recalls

Recall events where this establishment is the recalling firm, matched on its FEI.

InitiatedEventClassStatusProductReasonSource
September 14, 202290937Class IIOngoingARIES SARS-CoV-2 Assay, REF: 50-10047A part defect with the wash 1 syringe of an SARS-CoV-2 assay could lead to incomplete extraction thereby producing an invalid or false negative assay result.accessdata.fda.gov
July 14, 202290698Class IIOngoingARIES SARS-CoV-2 AssaySARS-CoV-2 assay that detects SARS-CoV-2 ORF1ab and N genes may not detect the ORF1ab gene. A positive results if either SARS-CoV-2 genes is detected, but If both genes are mistakenly not detected, a false negative result would be generated.accessdata.fda.gov
April 5, 202290023Class IIOngoingVerigene Processor SP, Models 10-0000-07/10-0000-07R a component of the Verigene systemHeater within the Verigene System may be outside of established temperature limits for assays which could result in false negative results.accessdata.fda.gov
November 17, 202189244Class IITerminatedARIES HSV 1&2 Assay, Catalog/REF# 50-10017Impacted lot may leak inside the ARIES instrument. Testing confirmed a leak rate of 0.9%. Leaking cassettes could potentially lead to incorrect results or a delay in reporting results due to an Invalid.accessdata.fda.gov
April 16, 202189303Class IITerminatedARIES HSV 1&2 Assay, Part Number/REF 50-10017Impacted lot may leak inside the ARIES instrument.accessdata.fda.gov
June 15, 202085872Class IITerminatedVerigene Processor SP with assay: Luminex, VERIGENE Gram-Positive Blood Culture Nucleic Acid Test,BC-GP, IVD - Product Usage: utilizes a single-use disposable test consumables and a self-contained Verigene Test CartridgeAn instrument failure mode that may result in a Blood Culture Gram Positive (BC-GP) or Gram Negative (BC-GN) false negative call.accessdata.fda.gov
February 20, 201983470Class IIOngoingAries Bordetella Assay, REF 50-10037, UDI # 00840487101452Through internal investigation, it was discovered that a portion of side cassette assemblies (SCAs) back side seal (BSS) did not meet design specification, resulting in partially sealed SCAs. The impact of a partial seal of the BSS could result in potential decrease of volume for each solution in the SCAs and decreased sensitivity or stability of the assay.accessdata.fda.gov
December 26, 201881890Class IIITerminatedVergene Amplification Tray - 700uL, BC-GP REF 20-011-018 The Verigene(R) Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed using the sample-to-result Verigene System is a qualitative, multiplexed in vitro dOn lot of VERIGENE(R) BC-GP Utility Kits (20-011-018) were labeled with the VERIGENE(R) Amplification Tray label.accessdata.fda.gov
December 10, 201886358Class IIOngoingVERIGENE Processor SP Model No. 10-0000-07. An in vitro diagnostic device intended for processing and identifying nucleic acidsNo results/incorrect results due to failure of the hybridization heater.accessdata.fda.gov
September 14, 201881220Class IITerminatedVERIGENE Blood Culture Gram-Positive Nucleic Acid Kits (packaged as five-pack carriers) Product Usage: In vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive baPotential to lead to a false negative results.accessdata.fda.gov
June 29, 201881420Class IITerminatedLuminex Aries M1 System Model: Aries M6V1 Aries Software v1.0 For In Vitro Diagnostic Use in clinical laboratories. Scanner Label/Labeling: JADAK JDK-2330 REV B 170512-017An incorrect control board and firmware installed in some of the Hand Held Barcode Scanners could result in sample/patient mismatch or duplicate results (from other patients specimens) for a patient order.accessdata.fda.gov
May 8, 201880517Class IITerminatedVerigene Enteric Pathogens Nucleic Acid Test (EP) for detecting and identification of pathogenic enteric bacteria, viruses, and genetic virulence markers from liquid or soft stool preserved in Cary-Blair medium, collecteElevated false positive results Yersinia enterocolitica (Yersinia) from customers using the EP Nucleic Acid Test Cartridges component (20-006-023) from the Verigene EP Nucleic Acid Test Kit (20-005-023).accessdata.fda.gov
April 19, 201777052Class IITerminatedARIES System and ARIES M1 SystemThe hand-held barcode scanner that is used as an accessory to enter ARIES cassette and specimen identifications on the ARIES Systems populates patient sample IDs with a previously scanned sample ID when entering orders into an ARIES instrument.accessdata.fda.gov
May 24, 201159345Not yet classifiedTerminatedxTAG CYP2D6 Kit v3 IVD For use with Luminex 100/200 Instrument Luminex Molecular Diagnostics, Inc. 439 University Ave. Toronto, Ontario Canada Catalog # I030B0373 The xTAG CYP2D6 Kit v3 is a device used to simultaneouslyInaccurate test results, due to possible defective primers, which could lead to incorrect dosage on manufactured drug assays.accessdata.fda.gov

Compare with other makers

Updated October 26, 2022. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.